Clinical trial
Randomized, Double-blind Clinical Trial on the Efficacy and Safety of Gut Microbiota Transplantation (FMT) in the Treatment of Moderate to Severe Acute Pancreatitis
NCT07153809 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double-blind Clinical Trial on the Efficacy and Safety of Gut Microbiota Transplantation (FMT) in the Treatment of Moderate to Severe Acute Pancreatitis
- Lead sponsor
- Changhai Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 12, 2024
- Completion date
- December 31, 2026
- Enrollment
- 80 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acute pancreatitis, severe acute pancreatitis